| Revenue | NOK 1B | +3% |
| EBITDA | NOK 36,2M | +4% |
| Net profit | NOK 49,8M | -20% |
| Total assets | NOK 943,7M | -2% |
| Equity | NOK 548,4M | -13% |
| Employees | 47 | — |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 843 176 | 872 723 | 915 851 | 977 308 | 1 007 240 |
| Staff expenses | −0 | −74 225 | −0 | −0 | −0 |
| EBITDA | 24 044 | 29 988 | 30 219 | 34 849 | 36 168 |
| Depreciation & amort. | −80 | −9 | −22 | −327 | −383 |
| EBIT | 23 964 | 29 979 | 30 198 | 34 522 | 35 785 |
| Net financials | 1 188 | 45 936 | 27 231 | 36 536 | 23 559 |
| Profit before tax | 25 152 | 75 915 | 57 428 | 71 059 | 59 344 |
| Tax | −0 | 7 010 | −0 | −0 | −0 |
| Net profit | 19 545 | 68 904 | 50 175 | 62 596 | 49 831 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 953 359 | 946 420 | 919 696 | 965 054 | 943 651 |
| Equity | 636 899 | 635 803 | 635 978 | 628 574 | 548 405 |
| Long-term debt | 468 | 0 | 1 486 | 1 762 | 307 |
| Short-term debt | 299 140 | 293 529 | 267 931 | 334 718 | 394 940 |
| Total debt | 299 608 | 293 529 | 269 417 | 336 479 | 395 247 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BG Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
PS Chief Executive Officer | Chief Executive Officer | 2019 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Chairman | 2021 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Medtronic Holding Bv | Company | 100% | 100% | 2024 |
| Person | Role here | Other companies |
|---|---|---|
| Panu Samuel Lauha | Chief Executive Officer | 0 companies |
| Birgitte Galuzick Broe | Chief Executive Officer | 0 companies |
| Jon Olav Utgaard | Board of Directors | 0 companies |
| Wilhelmus Johannes Maria Van Zuilen | Chairman | 0 companies |
| Håkon Wennberg | Board of Directors | 0 companies |